Literature DB >> 11858710

Methods for preparation of recombinant cytokine proteins V. mutant analogues of human interferon-gamma with higher stability and activity.

Sergey E Pechenov1, Roman V Tikhonov, Lyudmila N Shingarova, Vyacheslav G Korobko, Sergey A Yakimov, Vadim E Klyushnichenko, Alla A Babajantz, Dmitriy L Beliaev, Vladimir P Kuznetzov, Vitaliy I Shvetz, Andrey N Wulfson.   

Abstract

Mutant analogues of recombinant human immune interferon (IFN-gamma) with higher stability and biological activity were prepared. Depending on the analogue, protein structure modification might involve introduction of an intramonomer disulfide bond (through replacements of Glu7Cys and Ser69Cys), C-terminal shortening by 10 amino acid residues, as well as Gln133Leu substitution in truncated variant. Isolation, purification, and renaturation of the IFN-gamma analogues expressed in Escherichia coli as inclusion bodies were performed according to the scheme developed earlier for wild-type protein. The main idea of this scheme is to remove cellular impurities before recombinant protein renaturation. Folding kinetics of IFN-gamma was studied by reversed-phase HPLC. IFN-gamma and mutant proteins were characterized by their thermal stability and biological activity. Introduction of the intramolecular disulfide bond together with C-terminal shortening and replacement of C-terminal residue was shown to result in increasing the thermal stability by 19 degrees C and four times enhancement of biological activity compared with intact IFN-gamma molecule. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858710     DOI: 10.1006/prep.2001.1565

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography.

Authors:  Praveen K Reddy; Srinivasa G Reddy; Venkata R Narala; Sangita S Majee; Sudhakar Konda; Sripad Gunwar; Raju C Reddy
Journal:  Protein Expr Purif       Date:  2006-09-06       Impact factor: 1.650

2.  Process development for production of recombinant human interferon-gamma expressed in Escherichia coli.

Authors:  R Khalilzadeh; S A Shojaosadati; N Maghsoudi; J Mohammadian-Mosaabadi; M R Mohammadi; A Bahrami; N Maleksabet; M A Nassiri-Khalilli; M Ebrahimi; H Naderimanesh
Journal:  J Ind Microbiol Biotechnol       Date:  2004-02-19       Impact factor: 3.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.